Mufg Securities Emea PLC Bristol Myers Squibb CO Transaction History
Mufg Securities Emea PLC
- $5.71 Billion
- Q4 2024
A detailed history of Mufg Securities Emea PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mufg Securities Emea PLC holds 171,000 shares of BMY stock, worth $10.4 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
171,000
Previous 125,999
35.72%
Holding current value
$10.4 Million
Previous $6.52 Million
48.33%
% of portfolio
0.17%
Previous 0.26%
Shares
16 transactions
Others Institutions Holding BMY
# of Institutions
2,771Shares Held
1.56BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.68 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.86 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.8 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.68 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $130B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...